ReceptorPharma has the goal to develop new Alzheimer’s drugs through a completely new pathway and mechanism. We are utilizing the very latest research and findings regarding disease-coupled genes and combining it with the usage of one of the most well-studied drug target protein families.
This novel approach to create a new generation of Alzheimer’s disease drugs that act through is our competitive advantage and where our competences shine.
In addition to Alzheimer’s disease, our approach will allow for the development of new drugs for several additional debilitating diseases, including certain types of cancer, through similar mechanisms using disease-coupled as drug targets.
Company Details
- Founded
- -
- Address
- 838 Walker Rd,
- in****@****rma.com
- Industry
- Biotechnology
- Website
- receptorpharma.com
- Keywords
- Gebauer Company.
- HQ
- Dover, Delaware
Receptorpharma Inc Questions
Receptorpharma Inc's website is receptorpharma.com
Receptorpharma Inc's LinkedIn profile is https://www.linkedin.com/company/receptorpharma
Receptorpharma Inc's industry is
Biotechnology
Receptorpharma Inc's top competitors are
Assetwatch®,
Astrid Pharma,
Nec Bio Therapeutics Gmbh,
Gebauer Company,
Olive Branch Mentorship Inc..
Receptorpharma Inc's support email address is info@receptorpharma.com
Receptorpharma Inc's categories are Biotechnology
Receptorpharma Inc's founding year is 2017
